2019-nCoV S1+S2 protein (C-His) (STJP000021) STJP000021-100 上海玉博生物科技有限公司

2019-nCoV S1+S2 protein (C-His) (STJP000021)

如果您对该产品感兴趣的话，可以
产品名称：2019-nCoV S1+S2 protein (C-His) (STJP000021)
产品型号：STJP000021-100
产品展商：ST john's laboratory
产品文档：无相关文档

简单介绍

2019-nCoV S1+S2 protein (C-His) (STJP000021)

产品描述

Host:	HEK293 cells
Note:	STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description:	2019-nCoV S1+S2-C-His protein was developed from hek293 cells and has a target region of C-His. For use in research applications.

Formulation:	Supplied as a 0.22 Mu m filtered solution in PBS, pH 7.4. Contact us for customized product form or formulation.
Immunoreactivity:	Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-CoV-2 Spike S1+S2 ECD-His at 2 Mu g/mL (100 Mu L/well) can bind Recombinant Human ACE2 with a linear range of 0.15-9.92 ng/mL.

Immunogen Region:	S-ECD
Immunogen:	Recombinant SARS-COV-2 Spike S1+S2 ECD (S-ECD) Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Val11-Gln1208) of SARS-COV-2 (2019-nCoV) S1+S2 ECD (S-ECD) (Accession #YP_009724390.1) fused with a 6

Background

Active Recombinant SARS-COV-2 Spike S1+S2 ECD (S-ECD) Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Val11-Gln1208) of SARS-COV-2 (2019-nCoV) S1+S2 ECD (S-ECD) (Accession #YP_009724390.1) fused with a 6×His tag at the C-terminus.

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance

产品留言

标题

联系人

联系电话

内容

验证码

点击换一张

注：1.可以使用快捷键Alt+S或Ctrl+Enter发送信息!
2.如有必要,请您留下您的详细联系方式!

温馨提示：为规避购买风险，建议您在购买前务必确认供应商资质与产品质量。
免责申明：以上内容为注册会员自行发布，若信息的真实性、合法性存在争议，平台将会监督协助处理，欢迎举报

产品目录

产品资料

2019-nCoV S1+S2 protein (C-His) (STJP000021)